Science Explorer Back to mapMap
Discussion
Company · Rockville · United States

OriGene (United States)

origene.comROR OpenAlex
Research works
44
▼ 10% vs 2018-21
Citations
806
18.1 per fractional work
Top-10% rate
10.1%
all institutions 10.0%
Open access
30%
world 40%
International
44%
world 18%
OriGene (United States)

Not ranked overall: OriGene (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does OriGene (United States) work in?

In all years, 51% of research at OriGene (United States) is in Life Sciences, 32% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (43%), Medicine (31%), Immunology and Microbiology (7%). It does 2.7× the world's share of Life Sciences.

Life Sciences: 23 fractional works · 51.2% of its workBiochemistry, Genetics and Molecular Biology: 19 fractional works · 42.6% of its workMolecular Biology: 14 fractional works · 30.7% of its workGenetics: 2 fractional works · 4.1% of its workCancer Research: 1 fractional works · 3.4% of its workBiotechnology: 1 fractional works · 2.4% of its workBiophysics: 0 fractional works · 0.9% of its workCell Biology: 0 fractional works · 0.8% of its workPhysiology: 0 fractional works · 0.2% of its workImmunology and Microbiology: 3 fractional works · 6.8% of its workImmunology: 3 fractional works · 6.8% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 1 fractional works · 1.2% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.7% of its workDevelopmental Neuroscience: 0 fractional works · 0.5% of its workAgricultural and Biological Sciences: 0 fractional works · 0.6% of its workAnimal Science and Zoology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workHealth Sciences: 14 fractional works · 31.6% of its workMedicine: 14 fractional works · 31.3% of its workOncology: 6 fractional works · 14.1% of its workRadiology, Nuclear Medicine and Imaging: 3 fractional works · 5.7% of its workPulmonary and Respiratory Medicine: 2 fractional works · 4.9% of its workImmunology and Allergy: 1 fractional works · 1.2% of its workEpidemiology: 0 fractional works · 1.0% of its workInfectious Diseases: 0 fractional works · 0.9% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.7% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.6% of its workPathology and Forensic Medicine: 0 fractional works · 0.4% of its workHepatology: 0 fractional works · 0.4% of its workReproductive Medicine: 0 fractional works · 0.4% of its workSurgery: 0 fractional works · 0.4% of its workHematology: 0 fractional works · 0.3% of its workGenetics: 0 fractional works · 0.2% of its workNursing: 0 fractional works · 0.4% of its workNutrition and Dietetics: 0 fractional works · 0.4% of its workPhysical Sciences: 5 fractional works · 11.0% of its workEngineering: 2 fractional works · 5.2% of its workArchitecture: 1 fractional works · 2.3% of its workBiomedical Engineering: 1 fractional works · 2.2% of its workComputational Mechanics: 0 fractional works · 0.7% of its workComputer Science: 2 fractional works · 3.4% of its workArtificial Intelligence: 1 fractional works · 1.5% of its workSignal Processing: 0 fractional works · 0.7% of its workHardware and Architecture: 0 fractional works · 0.6% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.5% of its workChemistry: 0 fractional works · 1.1% of its workOrganic Chemistry: 0 fractional works · 1.1% of its workMaterials Science: 0 fractional works · 1.1% of its workBiomaterials: 0 fractional works · 0.6% of its workPolymers and Plastics: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysics and Astronomy: 0 fractional works · 0.2% of its workSocial Sciences: 3 fractional works · 6.1% of its workSocial Sciences: 2 fractional works · 4.7% of its workLaw: 1 fractional works · 1.3% of its workSociology and Political Science: 1 fractional works · 1.3% of its workEducation: 0 fractional works · 0.6% of its workPolitical Science and International Relations: 0 fractional works · 0.6% of its workAnthropology: 0 fractional works · 0.5% of its workCommunication: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workArts and Humanities: 1 fractional works · 1.1% of its workArcheology: 0 fractional works · 0.4% of its workLanguage and Linguistics: 0 fractional works · 0.3% of its workLiterature and Literary Theory: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.2% of its workEconomics and Econometrics: 0 fractional works · 0.2% of its workALL ITS WORKOriGene (UnitedStates)44fractional works, all years
Life Sciences51%Physical Sciences11%Health Sciences32%Social Sciences6%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 14 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1942.6%
    2. Immunology and Microbiology36.8%
    3. Neuroscience11.2%
    4. Agricultural and Biological Sciences00.6%
    1. Medicine1431.3%
    2. Nursing00.4%
    1. Engineering25.2%
    2. Computer Science23.4%
    3. Chemistry01.1%
    4. Materials Science01.1%
    5. Physics and Astronomy00.2%
    1. Social Sciences24.7%
    2. Arts and Humanities11.1%
    3. Economics, Econometrics and Finance00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 7.31× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 23.34× its world share, 2 worksImmunology and Micro…Computer Science: 0.97× its world share, 1 worksComputer ScienceEngineering: 0.61× its world share, 1 worksEngineeringMedicine: 0.89× its world share, 2 worksMedicineEconomics, Econometrics and Finance: 0.59× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.20× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 23.3×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Immunology and Microbiology23.34×2 works
  2. Biochemistry, Genetics and Molecular Biology7.31×4 works
  3. Computer Science0.97×1 works
  4. Medicine0.89×2 works
  5. Engineering0.61×1 works
  6. Economics, Econometrics and Finance0.59×0 works
  7. Social Sciences0.20×0 works

Who are the top researchers at OriGene (United States)?

Ranked on the quality score, Wei-Wu He, Donghui Ma and Caiwei Chen lead among researchers whose main affiliation is OriGene (United States).

  1. 1 Wei-Wu He United States · #440,158 worldwide 3.1k citations · 45 works
  2. 2 Donghui Ma United States · #914,689 worldwide 2.1k citations · 110 works
  3. 3 Caiwei Chen United States · #1,386,698 worldwide 337 citations · 135 works
  4. 4 Zairen Sun United States · #1,854,416 worldwide 805 citations · 17 works
  5. 5 Youmin Shu United States · #1,988,882 worldwide 1.1k citations · 24 works
  6. 6 Kehu Yuan United States · #2,070,511 worldwide 1.5k citations · 27 works
All ranked researchers at OriGene (United States)

What are the most cited papers from OriGene (United States)?

The most cited paper from OriGene (United States) is "Cloning, expression and chromosome locations of the human DNMT3 gene family" (Shaoping Xie, Zhenjuan Wang, Masaki Okano et al., 1999), with 428 citations. Next come "NLRX1 is a mitochondrial NOD‐like receptor that amplifies NF‐κB and JNK pathways by inducing reactive oxygen species production" (320) and "Induction of Pluripotency in Mouse Somatic Cells with Lineage Specifiers" (315).

Most cited papers
#PaperReleasedCitations
1 Cloning, expression and chromosome locations of the human DNMT3 gene family Shaoping Xie, Zhenjuan Wang, Masaki Okano et al. · Gene Aug 1999 428
2 NLRX1 is a mitochondrial NOD‐like receptor that amplifies NF‐κB and JNK pathways by inducing reactive oxygen species production Ivan Tattoli, Letícia A. M. Carneiro, Muguette Jéhanno et al. · EMBO Reports Open access 25 Jan 2008 320
3 Induction of Pluripotency in Mouse Somatic Cells with Lineage Specifiers Jian Shu et al. · Cell Open access May 2013 315
4 Cabin 1, A Negative Regulator for Calcineurin Signaling in T Lymphocytes Luo Sun, Hong‐Duk Youn, Christine Loh et al. · Immunity Open access Jun 1998 241
5 Application of Active and Kinase-Deficient Kinome Collection for Identification of Kinases Regulating Hedgehog Signaling Markku T Varjosalo, Mikael Björklund, Fang Cheng et al. · Cell Open access May 2008 186
All 61 most cited papers, with filters and sorting

Which keywords describe research at OriGene (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer, Glycosylation, Genome Engineering, RNA-Guided, Tumor Microenvironment, Gene Expression, Immunity and Fc Receptors.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer4▲ 7.2×11 topics
  2. Glycosylation4▲ 43×3 topics
  3. Genome Engineering3▲ 115×1 topic
  4. RNA-Guided3▲ 115×1 topic
  5. Tumor Microenvironment3▲ 19×5 topics
  6. Gene Expression3▲ 9.9×8 topics
  7. Immunity3▲ 17×5 topics
  8. Breast Cancer2▲ 20×3 topics
  9. Fc Receptors2▲ 57×1 topic
  10. Therapeutic Antibodies2▲ 44×1 topic
  11. High-Throughput Analysis2▲ 113×1 topic
  12. Immunotherapy2▲ 7.8×5 topics
  13. Protein Microarrays2▲ 260×1 topic
  14. Gene Therapy2▲ 18×4 topics
  15. Innate Immunity2▲ 14×4 topics
  16. Monoclonal Antibody2▲ 72×2 topics
  17. Chemotherapy2▲ 6.5×2 topics
  18. Metastatic2▲ 73×2 topics
  19. Cancer Immunotherapy2▲ 30×3 topics
  20. Cancer Stem Cells2▲ 98×1 topic
  21. HER22▲ 140×1 topic
  22. Trastuzumab2▲ 99×1 topic
  23. Tumor Metastasis2▲ 70×1 topic
  24. Antigen Presentation2▲ 41×2 topics
  25. Tumor Targeting2▲ 31×3 topics
  26. Dendritic Cells2▲ 32×1 topic
  27. Nanoparticles2▲ 3.0×6 topics
  28. Tumor Antigen2▲ 46×1 topic
  29. Genomic Integration1▲ 30×2 topics
  30. Immune Checkpoint Blockade1▲ 55×1 topic
  31. PD-1 and PD-L11▲ 55×1 topic
  32. Therapeutics1▲ 23×2 topics
  33. Glycans1▲ 36×1 topic
  34. Immune System1▲ 9.1×1 topic
  35. Feature Selection1▲ 15×3 topics
  36. Biopharmaceutical Production1▲ 31×2 topics
  37. EGFR Mutations1▲ 45×1 topic
  38. Embryonic Stem Cells1▲ 32×2 topics
  39. Targeted Therapy1▲ 12×1 topic
  40. Tumor Regression1▲ 29×2 topics

Which research topics does OriGene (United States) publish most on?

By volume in 2022-now: Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Cancer, Hypoxia, and Metabolism and Nanoplatforms for cancer theranostics.

Immunotherapy and Immune…2Immunotherapy and Immune Responses: 2 fractional worksCancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksCancer, Hypoxia, and Met…1Cancer, Hypoxia, and Metabolism: 1 fractional worksNanoplatforms for cancer theranostics: 0 fractional worksSingle-cell and spatial transcriptomics: 0 fractional worksExtracellular vesicles in disease: 0 fractional worksHER2/EGFR in Cancer Research: 0 fractional worksCell Image Analysis Techniques: 0 fractional worksProtein Degradation and Inhibitors: 0 fractional worksAdvanced Adaptive Filtering Techniques: 0 fractional works
ImmunologyOncologyCancer ResearchBiomedical Engineering3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Immunotherapy and Immune Responses Immunology 2 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 1 works
  3. 3 Cancer, Hypoxia, and Metabolism Cancer Research 1 works
  4. 4 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
  5. 5 Single-cell and spatial transcriptomics Molecular Biology 0 works
  6. 6 Extracellular vesicles in disease Molecular Biology 0 works
  7. 7 HER2/EGFR in Cancer Research Oncology 0 works
  8. 8 Cell Image Analysis Techniques Biophysics 0 works
  9. 9 Protein Degradation and Inhibitors Molecular Biology 0 works
  10. 10 Advanced Adaptive Filtering Techniques Computational Mechanics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.0%not open70.0%

World: 40% of research is openly available.

with international co-authors44.3%domestic only55.7%

World: 18% is written across borders.

How has OriGene (United States)'s research output changed?

Output in 2022-2025 was 10% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is OriGene (United States) as a percentage of every work published that year, 0.000022% in 2024.

still counting0.00010%0.00020%0.00030%OriGene (United States)0.000020% in 202519801990200020102020

Fractional works of OriGene (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Rockville

All research institutions in Rockville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about OriGene (United States). Posts are plain text and can be reported.